Glioblastoma Multiforme (GBM) Pipeline Review, H2 2012 New Report
Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glioblastoma Multiforme (GBM).
View full press release